研報掘金丨華福證券:穩健醫療核心產品增長驅動強勁,維持“買入”評級
華福證券研報指出,看好穩健醫療衛生巾品牌成長性、渠道紅利與差異化。2025年公司醫療板塊內生業務有望迴歸常態化疊加併購貢獻,同時消費品大單品勢能快速提升,全棉+安全品牌價值值得重視。預計2025-2027年公司歸母淨利潤分別爲10.4億元、12.4億元、14.7億元,分別同比+50.1%、+19.0%、+18.8%(維持前值),目前股價對應25年PE爲23X。考慮到公司醫療+消費、全棉+健康的業務模式與品牌屬性稀缺,核心產品增長驅動強勁,維持“買入”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.